ActivePharmaceutical
IngredientsCatalog
2021
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
Canagli�ozin*
Dapagli�ozin*
Glimepiride
Linagliptin
PioglitazoneHydrochlorideAN
TI-D
IABE
TIC
Available
Available
Available
Available
Available
Liraglutide Available
Semaglutide Available
Ferric Carboxymaltose (Available for selected markets)
Gati�oxacin
Levo�oxacinHemihydrateMoxi�oxacin
Hydrochloride
Posaconazole
Terbina�neHydrochloride
Voriconazole
AmlodipineBesylate
Apixaban
AtorvastatinCalcium*
ClopidogrelBisulfate*
DabigatranEtexilate Mesylate
DoxazosinMesylateEnalaprilMaleate
FondaparinuxSodium
Irbesartan
CARD
IOVA
SCUL
ARAN
TI-I
NFEC
TIVE
Available
Available
Available
Available
Available
Available
Available
Available
Available
Candesartan Available
Available
Available
Available
Available
Available
Available
Available
Available
Iron Sucrose(Available for selected markets)
Lacidipine
Available
Available
LosartanPotassium Available
HCQS Available
Clopidogrel Bisulfate Form 2 Available
Enalaprilat
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
Ranolazine
Rivaroxaban
Sacubitril /Valsartan
Telmisartan
Ticagrelor
Treprostinil
Valsartan
AsenapineMaleate
AtomoxetineHydrochloride
BenztropineMesylate
Dimethyl Fumarate
Divalproex Sodium
Donepezil HCl
EscitalopramOxalate
EslicarbazepineAcetate
Eszopiclone
FingolimodHydrochloride
Glatiramer Acetate
Levetiracetam
LurasidoneHydrochloride
CENT
RAL
NERV
OUS
SYST
EMCA
RDIO
VASC
ULAR
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
UD
Ferumoxytol(Available for selected markets) UD
Bempedoic Acid
UDTafamidisFree Acid
UDTafamidisMeglumine
Olanzapine Available
AvailableEdaravone
Roxadustat* Available
MemantineHydrochloride Available
AvailableDiroximel Fumarate
Ramipril Available
MetoprololSuccinate Available
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
RivastigmineHydrogen Tartrat
TizanidineHydrochloride
VilazodoneHydrochloride
ZiprasidoneHydrochloride
EsomeprazoleMagnesium*
Famotidine
Lubiprostone
Nizatidine
Obeticholic Acid
Omeprazole
OmeprazoleMagnesium
PantoprazoleSodium
RabeprazoleSodium*
Apremilast*
RaloxifeneHydrochloride
AbirateroneAcetate
Azacitidine
BendamustineHydrochloride
Bortezomib
Cabazitaxel
Capecitabine
ONCO
LOGY
GAST
RO-I
NTES
TINA
LCE
NTRA
L NE
RVOU
S SY
STEM
MUS
CULO
-SK
ELET
AL
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Siponimod* UD
LumateperoneTosylate UD
Abaloparatide UD
Decitabine Available
QuetiapineFumarate
Risperidone
Available
Available
Pregabalin Available
Car�lzomib Available
Apalutamide* Available
Dasatinib(Available for selected markets) Available
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
Enzalutamide*
GemcitabineHydrochloride
Granisteron
IbandronateSodium
Ibrutinib*
Lenalidomide*
Lenvatinib*
Lomustine
NilotinibHydrochloride*
OndansetronHydrochloride
Palbociclib
PalonosetronHydrochloride
PemetrexedDisodium*
PemetrexedDitromethamine
Plerixafor
Pomalidomide
Venetoclax
Zoledronic Acid
Eribulin(Available for selected markets)
Fosaprepitant
Midostaurin*
ONCO
LOGY
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
OndansetronBase Available
Available
Available
Available
Available
Available
Available
Available
Available
UD
UD
Available
Available
Available
Olaparib*
Pazopanib
UDRuxolitinibPhosphate*
Docetaxel Available
UDCabozantinibS-Malate
UDIcotinib HCl
UDRelugolix
UDRipretinib
T H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZILT H ER A P Y A R EA PRODUCT NAME FILINGSTATUS DR. REDDY’S IP ORAL INJ US DMF CEP EU CDMF JP DMF KDMF RUSSIA BRAZIL
CetirizineDihydrochloride
Desloratadine
FexofenadineHydrochloride*Levocetirizine
Dihydrochloride
MontelukastSodium
Za�rlukast
Dutasteride
EliglustatHemitartrate
Febuxostat
Finasteride*
Mirabegron*
Testosterone
Icatibant Acetate
Li�tegrast
Permethrin
SugammadexSodium
UROL
OGY
RESP
IRAT
ORY
OTHE
RS
KetorolacTromethamine
Naproxen
NaproxenSodium
NaratriptanHydrochloride
SumatriptanSuccinate
PAIN
MAN
AGEM
ENT
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Available
Remdesivir*(Available for selected markets) UD
UD
UD
Tofacitinib
Varenicline Tartrate
Elagolix Sodium Available
CinacalcetHydrochloride Available
Salcaprozpate Sodium (SNAC)
(Excipient for Oral Semaglutide)UD
Ivermectin UD
OTHER PIPELINE PRODUCTS
Development timeline to be checked with the Sales Manager
PRODUCT NAMETHERAPY AREA DR. REDDY’S IP ORAL INJ
Mavacamten
Deucravacitinib
Vonoprazan Fumarate
ONCOLOGY
DERMATOLOGY
GASTRO-INTESTINAL
CARDIOVASCULAR
Disclaimer: No information in this catalog - including any reference to any product or service - constitutes an o�er for sale, or be construed as representing an o�er for sale. Products protected under valid patents are not o�ered or supplied for commercial use. However, the research quantities of such products may be o�ered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
Sotorasib